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DObjectives: Despite improvements in the surgical management of neonates with the hypoplastic left heart
syndrome and its variants, there is a subset of children who have a high predicted mortality. We have analyzed
and report our results with the hybrid approach in the management of these high-risk patients.
Methods: Children identified by our selection criteria underwent the initial hybrid procedure performed in the
catheterization laboratory. This consists of surgical banding of the branch pulmonary arteries and stenting of
the arterial duct. This was followed 3 to 6 months later by the combined stage I and II Norwood operation or
biventricular repair.
Results: Between December 2005 and May 2008, 21 neonates were selected for the hybrid procedure, of whom
16 had typical hypoplastic left heart syndrome. The remaining 5 neonates had severe aortic stenosis with border-
line left ventricular dimensions or poor left ventricular function at presentation. Four neonates had a virtually in-
tact interatrial septum and required urgent intervention immediately after birth. There were 6 deaths as inpatients
or up to 30 days after the procedure and 1 interstage death before the combined stage I and II operation. Thus far,
of 12 babies who have undergone the next operation, 9 have had the combined stage I and II operation and 3 have
had a biventricular repair. Two of these 12 babies have died after the combined stage I and II operation.
Conclusion: A hybrid approach may be a valuable alternative to the management of high-risk neonates with
hypoplastic left heart syndrome and its variants. (J Thorac Cardiovasc Surg 2010;139:1211-5)Improvements have been made in the treatment of neonates
and infants with the hypoplastic left heart syndrome (HLHS)
and its variants.1,2 Although the overall survival is nowgreater
than 70% after the initial Norwood stage I palliation, there is
a subset of neonates in whom the mortality rate is high after
this type of operation.3 Factors that increase the risk include
birth weight less than 2.5 kg, aortic atresia, intact or restrictive
atrial septum, the presence of additional cardiac anomalies,
prematurity, associated severe noncardiac genetic abnormal-
ity, and postnatal collapse with a pH less than 7.4-9 Prolonged
cardiopulmonary bypass (CPB) and circulatory arrest are asso-
ciated with a high mortality.10,11 Any treatment strategy that
will reduce the need for prolonged CPB in the neonatal period
could theoretically lead to an improvement in the results.4,12-14
In our unit, between 1995 and 2007, 211 patients with
HLHS were treated surgically with the Norwood stage I op-
eration. There was an overall mortality rate before stage II of
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The Journal of Thoracic and Carwas a tendency toward a decrease in the 30-day mortality
in the second era, but there was an increase in the interstage
mortality. However, the mortality after stage II and stage III
operations was low (1.38% and 1.11 %). One of the risk
factors for a high mortality for the conventional Norwood
staged operation was neonates with a birth weight of less
than 2.5 kg (60%), and indeed there were no survivors
when the birth weight was below 2.0 kg. The hybrid
approach to the management of neonates with HLHS has
recently been used by Galantowicz and Cheatham,15 Bacha
and associates,4 and Akintuerk and colleagues.12 The en-
couraging results from these authors influenced us to adopt
the hybrid procedure in these neonates. The hybrid proce-
dure involves a team effort between the surgeon and the in-
terventional cardiologist working in the catheter laboratory
and consists of banding of the branch pulmonary arteries,
followed immediately by stenting of the arterial duct.METHODS AND PATIENTS
Since December 2005, 21 neonates were considered for a hybrid proce-
dure for the HLHS or its variants if their birth weight was less than 2.5 kg, or
irrespective of weight, if there was a possibility of a cerebral insult, intact or
near intact interatrial septum, aortic stenosis with borderline or poorly con-
tracting left ventricle, and other associated unusual anatomic variants. All
the neonates were discussed at the institutional multidisciplinary meeting
and a consensus was reached regarding the management strategy. Written
parental consent was obtained before the procedure. The introduction of
the procedure was approved under the ‘‘new treatment procedures proto-
col’’ of our institution.diovascular Surgery c Volume 139, Number 5 1211
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
HLHS ¼ hypoplastic left heart syndrome
LV ¼ left ventricular
NEC ¼ necrotizing enterocolitis
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DHLHS or its variants were diagnosed antenatally in 16 of the 21 neonates,
thus allowing a treatment strategy to be planned in advance of delivery and
for extensive prenatal counseling with the parents. There were 5 patients
with severe aortic stenosis with borderline left ventricular (LV) dimensions
who were initially considered possibly not suitable for a biventricular repair,
1 of whom had also had postnatal collapse. In these 5, additional balloon di-
lation of the aortic valve was carried out during the hybrid procedure
through a sheath placed in the ascending aorta. The average weight at birth
was 2.74 kg (range, 2.0–4.65 kg).
Hybrid Procedure
All the procedures were performed in the catheter laboratory under gen-
eral anesthesia. Median sternotomy was followed by bilateral branch pul-
monary artery banding with a piece of polytetrafluoroethylene cut from
a 3.5-mm tube graft and sutured in position over the branch pulmonary ar-
tery to an external diameter of 3 mm. This was secured further in position
with 5-0 Prolene polypropylene tacking suture (Ethicon, Inc, Somerville,
NJ) to the branch pulmonary arteries to prevent band migration.4 After
this, a purse-string suture was placed between the pulmonary valve and
the arterial duct. A 6F short sheath was introduced through the purse-string
suture with about 2 mm of the sheath extending into the lumen of the pul-
monary artery. Angiography was performed in the lateral projection (and
occasionally in the anteroposterior projection, if indicated), through the
sidearm of the sheath in the main pulmonary artery to define the anatomy
and measure the length and diameter of the arterial duct at several levels,
namely, at the pulmonary arterial and aortic ends. A 0.018-inch floppy guide
wire was maneuvered through the duct and placed in the descending aorta.
Prostaglandin infusion was stopped and heparin (30–50 IU/kg body weight)
was administered. A balloon-expandable premounted Genesis PSS stent
(Cordis, Corp, Miami, Fla) of an appropriate diameter and length was
chosen. This was usually 1 to 2 mm above the diameter of the duct and
was delivered over the guide wire and deployed in the arterial duct, covering
both the aortic and pulmonary ends. Correct position of the stent during the
deployment of the stent was confirmed angiographically. At the end of the
procedure, the sternum was closed in all the neonates, who were then trans-
ferred to the pediatric intensive care unit for further recovery.
Four of the neonates with an antenatally diagnosed additional intact or
near intact atrial septum were delivered by cesarean section adjacent to
the cardiac operating theater and were immediately transferred to the theater
for open surgical septectomy. This was performed with CPB and circulatory
arrest at 28C with venous inflow occlusion but no cardioplegic arrest. On
rewarming and weaning from CPB, bands were placed on the branch pul-
monary arteries after the oxygen saturation had stabilized. The neonate
was transferred to the catheter laboratory for ductal stenting through the ster-
notomy incision. The average bypass time for this procedure was 44.6 min-
utes and the average cardiac ischemic/circulatory arrest time was 5.6
minutes. Seven neonates with restrictive atrial septum underwent concom-
itant balloon atrial septostomy during or after the hybrid procedure with 1
requiring stenting of the atrial septum 2 days after the procedure.
All infants were closely followed up in the postoperative period until
they were ready for the combined stage I and II operation. They were inves-
tigated by echocardiography and cardiac magnetic resonance imaging be-
fore the next operation. Cardiac catheterization was not performed
routinely in these patients. The combined stage I and II palliation consisted1212 The Journal of Thoracic and Cardiovascular Surof removal of the ductal stent, reconstruction of the ascending aorta and aor-
tic arch with a homograft patch, Damus–Kay–Stansel type anastomosis, and
a hemi-Fontan procedure. The latter involved a bidirectional cavopulmo-
nary anastomosis in preparation for the completion of total cavopulmonary
connection later with a baffle at the junction between the superior vena cava
and the right atrium.RESULTS
Patient characteristics and survival are as summarized in
Table 1.
The anatomic subsets of the patients as diagnosed by
echocardiography are summarized in Figure 1.
Five of the patients with true HLHS showed hemodynam-
ically significant tricuspid regurgitation. One of these
patients had severe rhythm disturbances, another had as-
phyxia requiring cardiopulmonary resuscitation in the im-
mediate postnatal period, and 1 had aortopulmonary
collaterals in addition to HLHS.Mortality
There were 6 deaths after the hybrid procedure. One
patient with aortic atresia had preoperative recurrent tachyar-
rhythmias and bradyarrhythmias and was acidotic when he
underwent the procedure. Intraoperatively, further severe
rhythm disturbances developed, as well as profound ventric-
ular dysfunction after stent deployment. The possible reason
could have been compromised coronary blood flow in view
of the diminutive aorta and possible distortion of the ascend-
ing aorta by the stent before it was deployed fully. After re-
positioning of the stent, the native aorta and the coronary
arteries were unobstructed on angiography, but a similar ep-
isode of arrhythmia occurred in the postoperative period and
the patient died 19 hours after the procedure. A second
patient was profoundly acidotic and showed evidence of sys-
temic hypoperfusion before intervention, despite inotropic
support. An emergency hybrid procedure was performed,
but his condition continued to deteriorate after the procedure,
necrotizing enterocolitis (NEC) developed, and he died 5
days after the intervention. The third patient was found to
have pulmonary overcirculation after the hybrid procedure;
repeat angiogram revealed multiple major aortopulmonary
collateral arteries, which were coil closed. The infant’s con-
dition continued to deteriorate, and death occurred 48 hours
after the procedure. The fourth patient had an intact atrial
septum. She was delivered in the cardiac operating theater
and had atrial septectomy and pulmonary artery banding.
Because she was in unstable condition during and after the
procedure, requiring inotropic support, the stenting of the
patent ductus arteriosus was delayed by 36 hours. There
was evidence of pulmonary overcirculation and she died
24 hours after the procedure. The fifth patient had moderate
tricuspid valve regurgitation. After the hybrid procedure, the
tricuspid regurgitation worsenedwith low cardiac output and
the infant died 72 hours postoperatively. The sixth patientgery c May 2010
TABLE 1. Patient characteristics
No. Risk factor
Birth
weight (kg) Septectomy Septostomy
Time to
stage II (d) Mortality
Fetal
diagnosis NEC Anatomy
1 Weight 2.41 No Yes 220 No Yes No MA/AA
2 Intact septum 3.5 Yes No 190 No Yes No MA/AA
3 Intact septum 3.2 Yes No 165 No Yes No AA
4 CHARGE association 2.6 No No 285 No Yes Yes MS/AS
5 Postnatal collapse 2.58 Yes No 180 Yes Yes No MS/AS
6 ? Bivent repair 3.8 No No 392 No No No AS
7 Weight 2.4 No Yes Yes Yes Yes MA/AA
8 Associated cardiac anomaly 2.8 No No Yes No No MA/AA
9 Weight 2.2 No No 145 No Yes No AA
10 Weight 2.1 No Yes 89 Yes No No AA
11 Weight; associated anomaly 2.12 No No 246 No Yes No AA
12 ? Bivent repair 3.2 No No 321 No Yes No AS
13 Restrictive septum/?bivent repair 3.01 No Yes 483 No Yes Yes AS
14 Weight 2.4 No Yes No Yes Yes MA
15 Postnatal collapse 2.7 No No Yes Yes No MA
16 Intact septum 3 Yes No Yes Yes No AA
17 ? Bivent repair 2.6 No No Yes Yes No MS/AS
18 Weight 2.2 No No Yes Yes No MA/AA
19 Weight 2.2 No No No Yes No AA
20 ? Bivent repair 4.65 No Yes 195 No Yes Yes AS
21 Weight 2.0 No No No Yes No AA
AA, aortic atresia; AS, aortic stenosis; ? Bivent, possible biventricular repair, CHARGE, Coloboma of the eye, Heart defects, Atresia of the choanae, Retardation of growth and/or
development, Genital and/or urinary abnormalities, and Ear abnormalities and deafness; MA, mitral atresia, MS, mitral stenosis; NEC, necrotizing enterocolitis; TR, tricuspid re-
gurgitation.
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fourth postoperative day of suspected aspiration.
None of the patients with preoperative echocardiographi-
cally significant tricuspid regurgitation survived (Table 2).
Other Complications
Three patients had NEC, and 2 other neonates had suspi-
cion of but not definite NEC (2 patients were Bell16 stage II
and 3 were Bell stage I). Thus, there was a 23.8% incidence
of possible or definite NEC. One patient died, as mentioned
earlier, another patient required bowel resection after ileal
perforation, and the remaining 3 patients were treated
conservatively and all recovered.
One patient undergoing ballooning of the aortic valve had
cerebral hemorrhage 4months after the procedure. He recov-
ered completely from this.
Outcome
There was 1 interstage death of unknown cause at the lo-
cal hospital. Five patients required further interstage inter-
vention. Three of the 5 required an additional stent either
to cover previously uncovered ductal tissue or to overlap
a partially migrated previous stent. One patient with aortic
stenosis and borderline LV dimensions underwent repeat
balloon aortic valvotomy. One patient required mitral valve
repair before biventricular repair (Ross procedure).
Of the 14 survivors of the hybrid procedure, 9 underwent
combined stage I and II operation and a further 3 underwentThe Journal of Thoracic and Cara successful biventricular repair. The average time from the
hybrid to the next operative procedure was 242.6 days
(range, 89–483 days). The average CPB time for combined
stage I and II was 204.6 minutes (range, 134–436 minutes),
the average cumulative cardiac ischemic time was119.9
minutes (range, 56–270 minutes), and the average cumula-
tive circulatory arrest time was 67.1 minutes (range,
20–137 minutes). The average CPB time for the biventricu-
lar repair was 178minutes and the cardiac ischemic time was
142 minutes.
There were 2 deaths among 9 patients after combined
stage I and II procedure. One of these died of thrombosis
of the innominate vein and the branch pulmonary arteries be-
cause of hypoplasia of theses branches resulting in raised
pulmonary vascular resistance and inadequate forward
blood flow. The second patient did not tolerate the stage I
and II repair; the Glenn anastomosis was taken down and
a modified Blalock–Taussig shunt created. He continued
to have severe tricuspid regurgitation and died of low output
failure.
Two infants are being followed up and are awaiting stage
II palliation.
Biventricular Repair
Five patients with severe aortic stenosis with borderline
LV dimensions underwent the hybrid procedure combined
with aortic balloon valvuloplasty. Of these, 1 neonate died
of suspected aspiration 4 days after the hybrid procedure.diovascular Surgery c Volume 139, Number 5 1213
TABLE 2. Patients having hybrid operations (n ¼ 21)
Stage I survivors Stage II survivors
Low birth weight (n ¼ 9) 6/9 3/4
Intact/restrictive septum (n ¼ 4) 3/4 2/3
Asphyxia (n ¼ 3) 1/3 1/1
Boderline LV dimension (n¼ 5) 4/5 4/4.
Total: 21 14/21* 10/12
LV, Left ventricular. *Includes 1 interstage death.
AA, 7, 33%
AS, 4, 19%MA, 2, 10%
MS/AS, 3, 14%
MA/AA, 5, 24%
FIGURE 1. Anatomic subtypes.MA,Mitral atresia; AA, aortic atresia;MS,
mitral stenosis; AS, aortic stenosis.
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One of the 5 patients underwent the combined stage I and
II Norwood procedure because of persistently small LV
dimensions.DISCUSSION
The initial concept of banding the branch pulmonary
arteries and stenting the arterial duct in infants with HLHS
was reported by Gibbs and associates.14 This was aimed as
a bridge to cardiac transplantation. Subsequently, Akintuerk
and coworkers12 modified the technique, but in both the 2
parts of the procedure were performed separately, the pul-
monary artery banding in the theater and the stenting of
the arterial duct in the catheter laboratory. Galantowicz
and Cheatham15 and Bacha and associates4 modified this
to a true hybrid procedure, in which both the banding and
stenting are performed during the same procedure in the
catheter laboratory. We have used the approach developed
by Galantowicz and Cheatham.15
Stage I Norwood palliation for HLHS is now accepted as
a standard treatment. The overall survival is in excess of
70%. However, there is a subgroup of high-risk HLHS
and its variants which present a challenging clinical prob-
lem. Norwood type surgical approaches for these patients
have carried a high mortality rate.17 This is independent of
the size of the center and the number of patients treated.1,3,7
Children with low birth weight and asphyxia before surgery
do not tolerate CPB and total circulatory arrest; thus, these
are additional factors for high mortality. The hybrid strategy
of banding of bilateral pulmonary artery branches and ductal
stenting offers a possible solution, in which the cerebral and
coronary perfusion is maintained and the pulmonary vascu-
lature is protected from systemic pressure.8 This potentially
gains vital time to stabilize the patients, correct other noncar-
diac anomalies, and delay the Norwood operation.
In our series, the mortality after the hybrid procedure has
been lower than after the surgical approach in these high-1214 The Journal of Thoracic and Cardiovascular Surrisk patients. In infants with low birth weight, survival after
the hybrid procedure was 66% (6/9).Those infants with an
intact or near intact interatrial septum are another high-risk
group. Seventy-five percent (3/4) of this subgroup in our series
survived. Only 1 of the 3 infants who had had postnatal col-
lapse survived. A further point of interest relates to infants
with pre-existing hemodynamically significant tricuspid re-
gurgitation, none of whom survived. It is worth mentioning
that 3 of these also had other additional risk factors.
Our relatively small series is different from reports al-
ready published in the literature in that we focused on
high-risk infants.4,12 The combined stage I and II operation
carries a higher mortality risk than in the ‘‘standard’’ Nor-
wood procedure. The number of patients in this subgroup
is small so that it is difficult to identify any risk factors.
NEC has occurred in a significant number (23.8%) of in-
fants. This compares with an incidence of approximately
18% in all children undergoing the Norwood I palliation.18
Although diastolic runoff may contribute to the development
of NEC, further studies are required to identify the risk
factors.19
The combined stage I and II operation after the initial
hybrid procedure is a major undertaking. The operation is
longer and more complex. CPB may be prolonged, although
with increasing experience these times have been reduced.20
In some infants a significant narrowing of the aorta proximal
to the isthmus may develop. This may be due to variation in
flow after the stent or to progression of ductal constriction.
This may have relevance to the timing of combined stage I
and II operation because of the possible compromised cere-
bral and coronary perfusion.8,20
The hybrid approach allows for an alternative strategy for
the treatment of infants with aortic stenosis, with poor LV
function or borderline LV dimensions.13 Three of 4 surviv-
ing infants with aortic stenosis underwent a successful
biventricular repair, whereas 1 infant, because of lack of
left ventricular growth, underwent a combined stage I and
II operation.CONCLUSION
The hybrid approach is a satisfactory alternative in the
management of high-risk infants with HLHS and its vari-
ants. Although our results are encouraging, further studies
are required to identify risk factors. An important advantagegery c May 2010
Venugopal et al Congenital Heart Diseaseof this approach is in infants with aortic stenosis and border-
line LV dimensions in whom the left ventricle is given time
to grow enough to allow biventricular repair.C
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